GSK plc
As of Oct 23, 2026 close
- Market cap
- $104.01B
- P/E (TTM)
- 16.11
- Forward P/E
- 11.49
- Dividend yield
- 3.49%
- 52-week range
- $42.85$61.70
- Volume (live)
- -
- Avg. volume (3M)
- 4.87M
GSK (GSK) Stock Price & Financial Analysis
GSK Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $50.29 - $50.92 |
|---|---|
| 52-Week High | $61.70 |
| 52-Week Low | $42.85 |
| Open | $50.83 |
| Volume (last close) | 3.18M |
| Average Volume (3M) | 4.87M |
| Revenue (TTM) | 44.46B |
|---|---|
| Net Income (TTM) | 6.46B |
| Free Cash Flow (TTM) | 7.44B |
| EPS (TTM) | $3.16 |
| Profit Margin | 14.52% |
| Operating Margin | 20.70% |
| Return on Equity (ROE) | 28.07% |
| Debt to Equity | 1.06 |
| Annual Dividend | $1.79 |
|---|---|
| Dividend Yield | 3.49% |
| Payout Ratio | 56.45% |
| Last Dividend Ex-Date | Aug 14, 2026 |
| Market Cap | 104.01B |
|---|---|
| Shares Outstanding | 2.03B |
| P/E Ratio (TTM) | 16.11 |
| Forward P/E | 11.49 |
| Price to Sales (P/S) | 2.34 |
| Price to Book (P/B) | 4.52 |
| EV/EBITDA | 8.19 |
| 50-Day MA | $49.56 |
|---|---|
| 200-Day MA | $52.35 |
| 1-Year Change | +12.45% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
GSK at a Glance
As of the Oct 23, 2026 close, GSK (GSK) has a market capitalization of $104.01B. The stock trades at 16.1× trailing earnings, 11.5× forward earnings and 2.3× sales. Over the trailing twelve months it earned $6.46B on revenue of $44.46B (a 14.5% profit margin) and generated $7.44B of free cash flow. Revenue grew 5.0% year over year.
As of its latest reported balance sheet, it holds $4.16B in cash and securities against $24.39B of debt, a net debt position of $20.23B.
GSK pays a quarterly dividend totaling $1.79 per share a year, a 3.49% yield at the Oct 23, 2026 close, with a 56% payout ratio and 2 consecutive years of dividend increases.
The share price is up 12.5% over the past year. At $50.75 (the Oct 23, 2026 close) it sits within its 52-week range of $42.84 to $61.70, below its 200-day moving average of $52.35.
Based on 4 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $65.00, 28.1% above the Oct 23, 2026 close.
Frequently Asked Questions About GSK
What is the current stock price for GSK?
As of the Oct 23, 2026 close, GSK stock trades at $50.75. The 52-week range is $42.85–$61.70, with a day range of $50.29–$50.92.
What is the P/E ratio for GSK?
As of the Oct 23, 2026 close, GSK's trailing twelve-month (TTM) P/E ratio is 16.1, meaning investors pay $16.1 for every $1 of annual earnings. The forward P/E is 11.5, reflecting analyst expectations for future earnings. GSK operates in the Healthcare sector.
Does GSK pay dividends?
Yes, GSK pays a 3.49% annual dividend yield as of the Oct 23, 2026 close ($1.79 per share a year). The trailing twelve-month payout ratio is 56.5%. The most recent ex-dividend date was August 14, 2026.
What do analysts recommend for GSK?
Based on ratings from 4 professional analysts over the last 90 days, the consensus for GSK is Buy. The average 12-month price target is $65.00, a 28.1% upside from the Oct 23, 2026 close of $50.75.
What is the market cap of GSK?
As of the Oct 23, 2026 close, GSK's market capitalization is $103.07B, classifying it as a large-cap company. GSK operates in the Healthcare sector within the Drug Manufacturers - General industry.